Azodicarbonamide inhibits HIV-1 replication by targeting the nucleocapsid protein.
about
Inhibition of HIV-1 replication by a bis-thiadiazolbenzene-1,2-diamine that chelates zinc ions from retroviral nucleocapsid zinc fingersStructural determinants and mechanism of HIV-1 genome packagingTargeting Zinc Finger Domains with Small Molecules: Solution Structure and Binding Studies of the RanBP2-Type Zinc Finger of RBM5Multiple effects of an anti-human immunodeficiency virus nucleocapsid inhibitor on virus morphology and replication.Inhibition of acute-, latent-, and chronic-phase human immunodeficiency virus type 1 (HIV-1) replication by a bistriazoloacridone analog that selectively inhibits HIV-1 transcriptionTargeting of arenavirus RNA synthesis by a carboxamide-derivatized aromatic disulfide with virucidal activityVirucidal agents in the eve of manorapid synergyInactivation of HIV-1 nucleocapsid protein P7 by pyridinioalkanoyl thioesters. Characterization of reaction products and proposed mechanism of action.Emerging roles of zinc finger proteins in regulating adipogenesisNovel compounds in preclinical/early clinical development for the treatment of HIV infections.Anisotropic, Polarizable Molecular Mechanics Studies of Inter- and Intramolecular Interactions and Ligand-Macromolecule Complexes. A Bottom-Up Strategy.Advances in targeting nucleocapsid-nucleic acid interactions in HIV-1 therapy.Considerations and development of topical microbicides to inhibit the sexual transmission of HIV.New anti-HIV agents and targets.Understanding HIV resistance, fitness, replication capacity and compensation: targeting viral fitness as a therapeutic strategy.Development of a cell-based assay probing the specific interaction between the human immunodeficiency virus type 1 nucleocapsid and psi RNA in vivo.Beyond plasma membrane targeting: role of the MA domain of Gag in retroviral genome encapsidation.The next generation of HIV/AIDS drugs: novel and developmental antiHIV drugs and targets.Evaluation of Substituted 1,2,3-Dithiazoles as Inhibitors of the Feline Immunodeficiency Virus (FIV) Nucleocapsid Protein via a Proposed Zinc Ejection Mechanism.The Continuing Evolution of HIV-1 Therapy: Identification and Development of Novel Antiretroviral Agents Targeting Viral and Cellular Targets.Identification and characterization of a new type of inhibitor against the human immunodeficiency virus type-1 nucleocapsid protein.A phenyl-thiadiazolylidene-amine derivative ejects zinc from retroviral nucleocapsid zinc fingers and inactivates HIV virions.Novel compounds for the treatment of HIV type-1 infection.Emerging biological treatments for uterine cervical carcinoma.Antiviral Chemistry & Chemotherapy's current antiviral agents FactFile (2nd edition): retroviruses and hepadnaviruses.Targeting a Novel RNA-Protein Interaction for Therapeutic Intervention of Hantavirus Disease.Antiviral and virucidal activities against arenaviruses of zinc-finger active compounds.Mapping the binding site of colchicinoids on beta -tubulin. 2-Chloroacetyl-2-demethylthiocolchicine covalently reacts predominantly with cysteine 239 and secondarily with cysteine 354.
P2860
Q24605190-D4E94C6B-643A-4CD9-AB25-FC0C2EE33A31Q24632055-191DEBB9-66CC-45B4-AF1B-1D911FBF55C7Q27676146-0036B861-EB5D-4600-A9F2-1F79AF8AA854Q28343701-FB40E1A8-EABC-4D9B-9067-6026655BA51AQ28379402-17D04AA2-A992-47C6-8AFD-D9FDC1308D7EQ28535297-63CE82EB-7381-42C0-9968-CC68DC38FD77Q33701018-CDD0D83D-50C2-493B-8E5F-DD7663FC886CQ33901772-5E9350CE-A45F-49A3-8CC7-8187437D1986Q33909907-D9B35ACE-0C88-419C-9E01-02F33DC84D63Q33966254-9EA7A399-9C53-49C6-BBCA-F0205B2087B0Q34599612-374EF0D0-AEB1-47D1-AD26-5BD8283CB109Q34616490-F5F8DE8E-9DF5-43EF-934E-08FCC31C659FQ34768558-D7D23582-A6B2-456B-99E4-68E3E4F469D6Q34944447-F46F336F-0BF4-4FD5-B8B4-4799FCBDE97AQ35842525-71E78422-1610-45C8-9F3B-C6F847EACBF8Q35857711-26816241-C51D-45F0-A78D-D58ADCD3FF47Q35893976-62DEC182-9B4A-477C-8B96-5D5C7BB72704Q35917148-D8B356E3-9340-45B2-B706-609337D0E746Q36100795-981D8D1D-F16F-4DA7-862F-D76F96522F41Q36104509-15A7E159-5E1D-4CD7-BC8D-227F712C09B9Q36256762-098233FF-8745-4493-8AE7-8388F9A0AAC9Q36523852-36C9C457-D9C5-45E9-875E-2873902DC564Q37502492-942BE896-CABE-4A48-B5D4-C12F4D068760Q37540968-CEF9CFD1-DB47-40E5-ABFD-58805498C0D9Q40055204-3C9CDC68-F107-400D-B974-5F0AB172DBABQ40508940-8890FA21-9725-476A-927A-CD24BE22790AQ40618228-3F0854E9-0790-41E2-BD65-70DE562CC4EEQ52164986-B9058D17-A611-47F4-9C8E-61C7DA34B218
P2860
Azodicarbonamide inhibits HIV-1 replication by targeting the nucleocapsid protein.
description
1997 nî lūn-bûn
@nan
1997 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մարտին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
name
Azodicarbonamide inhibits HIV-1 replication by targeting the nucleocapsid protein.
@ast
Azodicarbonamide inhibits HIV-1 replication by targeting the nucleocapsid protein.
@en
Azodicarbonamide inhibits HIV-1 replication by targeting the nucleocapsid protein.
@nl
type
label
Azodicarbonamide inhibits HIV-1 replication by targeting the nucleocapsid protein.
@ast
Azodicarbonamide inhibits HIV-1 replication by targeting the nucleocapsid protein.
@en
Azodicarbonamide inhibits HIV-1 replication by targeting the nucleocapsid protein.
@nl
prefLabel
Azodicarbonamide inhibits HIV-1 replication by targeting the nucleocapsid protein.
@ast
Azodicarbonamide inhibits HIV-1 replication by targeting the nucleocapsid protein.
@en
Azodicarbonamide inhibits HIV-1 replication by targeting the nucleocapsid protein.
@nl
P2093
P2860
P356
P1433
P1476
Azodicarbonamide inhibits HIV-1 replication by targeting the nucleocapsid protein
@en
P2093
D G Covell
E A Sausville
J A Turpin
M F Summers
N B McDonnell
R D Haugwitz
P2860
P2888
P304
P356
10.1038/NM0397-341
P407
P577
1997-03-01T00:00:00Z